Inventor
LAWSON JOHN DAVID
US21 patents
⚠️ This page may combine multiple inventors who share the name “LAWSON JOHN DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MIRATI THERAPEUTICS INC
10 patentsUS11453683B1Sep 27, 2022
KRas G12D inhibitors
MIRATI THERAPEUTICS INC13 citations83
US10647715B2May 12, 2020
KRas G12C inhibitors
MIRATI THERAPEUTICS INC10 citations82
US11964989B2Apr 23, 2024
KRas G12D inhibitors
MIRATI THERAPEUTICS INC2 citations71
US12421253B2Sep 23, 2025
Tetrahydropyridopyrimidine pan-KRas inhibitors
MIRATI THERAPEUTICS INC1 citations63
US12304915B2May 20, 2025
SOS1 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11999753B2Jun 4, 2024
Tetrahydropyridopyrimidine pan-KRas inhibitors
MIRATI THERAPEUTICS INC1 citations61
US11702418B2Jul 18, 2023
SOS1 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11492351B2Nov 8, 2022
MTA-cooperative PRMT5 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11479551B2Oct 25, 2022
MTA-cooperative PRMT5 inhibitors
MIRATI THERAPEUTICS INC1 citations61
US12398154B2Aug 26, 2025
Azaquinazoline pan-KRas inhibitors
MIRATI THERAPEUTICS INC0 citations51
TAKEDA PHARMACEUTICALS CO
7 patentsUS9434743B2Sep 6, 2016
Indazole derivatives
TAKEDA PHARMACEUTICALS CO20 citations81
US10328089B2Jun 25, 2019
Fumagillol derivatives
TAKEDA PHARMACEUTICALS CO0 citations51
US10307414B2Jun 4, 2019
Pyridinyl and fused pyridinyl triazolone derivatives
TAKEDA PHARMACEUTICALS CO0 citations51
US9827255B2Nov 28, 2017
Fumagillol derivatives
TAKEDA PHARMACEUTICALS CO1 citations51
US9801872B2Oct 31, 2017
Pyridinyl and fused pyridinyl triazolone derivatives
TAKEDA PHARMACEUTICALS CO1 citations51
US9402841B2Aug 2, 2016
Pyridinyl and fused pyridinyl triazolone derivatives
TAKEDA PHARMACEUTICALS CO1 citations51
US9475816B2Oct 25, 2016
Substituted-1,4-dihydropyrazolo[4,3-b]indoles
TAKEDA PHARMACEUTICALS CO0 citations40